STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Aug. 31, 2015	Aug. 31, 2014
Cash flows from operating activities
Net income	$ 3,842,961	$ 3,025,491
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization of property and equipment	211,454	47,231
Amortization of capitalized computer software development costs	1,023,139	807,705
Amortization of Intellectual property	755,000	182,500
Stock-based compensation	295,243	144,327
Deferred income taxes	55,919	1,298,896
(Increase) decrease in
Accounts receivable	1,048,969	247,456
Revenues in excess of billings	(238,502)	0
Prepaid income taxes	748,359	(446,786)
Prepaid expenses and other assets	(104,836)	4,014
Increase (decrease) in
Accounts payable	19,443	(15,464)
Accrued payroll and other expenses	(355,567)	29,500
Accrued Bonus	1,000	60,000
Billings in excess of revenues	(239,906)	0
Accrued income taxes	43,602	0
Other liabilities	(19,860)	(19,859)
Deferred revenue	48,573	(58,857)
Net cash provided by operating activities	7,134,991	5,306,154
Cash flows from investing activities
Purchases of property and equipment	(71,369)	(24,486)
Purchase of intellectual property rights	0	(2,500,000)
Cash used to purchase Cognigen	(2,080,000)	0
Cash received in acquisition	190,184	0
Capitalized computer software development costs	(1,168,937)	(1,369,077)
Net cash provided by (used in) investing activities	(3,130,122)	(3,893,563)
Cash flows from financing activities
Payment of dividends	(3,375,566)	(3,075,585)
Payments on contracts payable	(750,000)	0
Proceeds from the exercise of stock options	57,043	98,625
Net cash (used in) financing activities of continuing operations	(4,068,523)	(2,976,960)
Net increase (decrease) in cash and cash equivalents	(63,654)	(1,564,369)
Cash and cash equivalents, beginning of year	8,614,929	10,179,298
Cash and cash equivalents, end of period	8,551,275	8,614,929
Supplemental disclosures of cash flow information
Interest paid	0	0
Income taxes paid	961,907	692,562
Non-Cash Investing and Financing
Stock issued for acquisition of Cognigen Corporation	3,277,170	0
Creation of contract liability for acquisition of Cognigen Corporation	1,854,404	0
Purchase of intellectual property rights with shares and notes payable	$ 0	$ 3,500,000